KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities-Reference-Cited by-同舟云学术

KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities

Published:2021-10-01 Issue:4 Volume:28 Page:176-182
ISSN:2093-940X
Container-title:Journal of Rheumatic Diseases
language:en
Short-container-title:J Rheum Dis

Author:

Kim Jinhyun¹,Koh Jung Hee²,Choi Sung Jae³,Jeon Chan Hong⁴,Kwok Seung-Ki⁵,Kim Seong-Kyu⁶,Choi Chan-Bum⁷,Lee Jaejoon⁸,Lee Changhoon⁹,Nam Eon Jeong¹⁰,Park Yong-Beom¹¹,Lee Shin-Seok¹²,Kim Tae-Hwan⁷,Park Sung-Hwan⁵,Koh Eun-Mi⁸,Yoo Dae-Hyun⁷,Song Yeong Wook¹³,Kim Hyoun-Ah¹⁴^ORCID,Shin Kichul¹⁵^ORCID,Choe Jung-Yoon⁶

Affiliation:

1. Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea

2. Division of Rheumatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Division of Rheumatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea

4. Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

5. Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

6. Division of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea

7. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea

8. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

9. Department of Internal Medicine, Wonkwang University Hospital, Iksan, Korea

10. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea

11. Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

12. Department of Rheumatology, Chonnam National University Hospital, Gwangju, Korea

13. Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

14. Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea

15. Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea

Publisher

Korean College of Rheumatology

Link

http://pdf.medrang.co.kr/JRD/2021/028/jrd-28-4-176.pdf

Reference37 articles.

1. Trial designs using real‐world data: The changing landscape of the regulatory approval process

2. Real-World Evidence — What Is It and What Can It Tell Us?

3. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

4. Gliklich RE, Dreyer NA, Leavy MB. Patient registries. In: Gliklich RE, Dreyer NA, Leavy MB, eds. Registries for evaluating patient outcomes: a user's guide. 3rd ed. Rockville (MD), Agency for Healthcare Research and Quality (US), 2014.

5. Biologics registers in RA: methodological aspects, current role and future applications

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data;Scientific Reports;2024-02-01

2. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry;Therapeutic Advances in Musculoskeletal Disease;2023-12-30

3. Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry;Arthritis Research & Therapy;2023-09-19

4. Association between the functional FCGR3AF158V and FCGR2AR131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta‐analysis;International Journal of Rheumatic Diseases;2023-04-28

5. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study;BioDrugs;2023-02-09